- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Pet Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pet Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Canine accounting for % of the Pet Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Attenuated Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pet Vaccine include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, and Eli Lilly, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pet Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Market segment by Application can be divided into
Canine
Avian
Feline
The key market players for global Pet Vaccine market are listed below:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Vaccine, with price, sales, revenue and global market share of Pet Vaccine from 2019 to 2022.
Chapter 3, the Pet Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pet Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pet Vaccine.
Chapter 13, 14, and 15, to describe Pet Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Pet Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pet Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Pet Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Global Pet Vaccine Market Size & Forecast
1.4.1 Global Pet Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pet Vaccine Sales in Volume (2017-2028)
1.4.3 Global Pet Vaccine Price (2017-2028)
1.5 Global Pet Vaccine Production Capacity Analysis
1.5.1 Global Pet Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Pet Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pet Vaccine Market Drivers
1.6.2 Pet Vaccine Market Restraints
1.6.3 Pet Vaccine Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 Bayer Healthcare
2.1.1 Bayer Healthcare Details
2.1.2 Bayer Healthcare Major Business
2.1.3 Bayer Healthcare Pet Vaccine Product and Services
2.1.4 Bayer Healthcare Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Vetoquinol S.A
2.2.1 Vetoquinol S.A Details
2.2.2 Vetoquinol S.A Major Business
2.2.3 Vetoquinol S.A Pet Vaccine Product and Services
2.2.4 Vetoquinol S.A Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Pet Vaccine Product and Services
2.3.4 Boehringer Ingelheim Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ceva
2.4.1 Ceva Details
2.4.2 Ceva Major Business
2.4.3 Ceva Pet Vaccine Product and Services
2.4.4 Ceva Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Pet Vaccine Product and Services
2.5.4 Eli Lilly Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Heska Co.
2.6.1 Heska Co. Details
2.6.2 Heska Co. Major Business
2.6.3 Heska Co. Pet Vaccine Product and Services
2.6.4 Heska Co. Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Pet Vaccine Product and Services
2.7.4 Merck Animal Health Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merial (Sanofi)
2.8.1 Merial (Sanofi) Details
2.8.2 Merial (Sanofi) Major Business
2.8.3 Merial (Sanofi) Pet Vaccine Product and Services
2.8.4 Merial (Sanofi) Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Virbac
2.9.1 Virbac Details
2.9.2 Virbac Major Business
2.9.3 Virbac Pet Vaccine Product and Services
2.9.4 Virbac Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Zoetis (Pfizer)
2.10.1 Zoetis (Pfizer) Details
2.10.2 Zoetis (Pfizer) Major Business
2.10.3 Zoetis (Pfizer) Pet Vaccine Product and Services
2.10.4 Zoetis (Pfizer) Pet Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pet Vaccine Breakdown Data by Manufacturer
3 Pet Vaccine Breakdown Data by Manufacturer
3.1 Global Pet Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pet Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pet Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Pet Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Pet Vaccine Manufacturer Market Share in 2021
3.5 Global Pet Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pet Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Pet Vaccine Market Size by Region
4.1.1 Global Pet Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Pet Vaccine Revenue by Region (2017-2028)
4.2 North America Pet Vaccine Revenue (2017-2028)
4.3 Europe Pet Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Pet Vaccine Revenue (2017-2028)
4.5 South America Pet Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Pet Vaccine Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Pet Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Pet Vaccine Revenue by Type (2017-2028)
5.3 Global Pet Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Pet Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Pet Vaccine Revenue by Application (2017-2028)
6.3 Global Pet Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Pet Vaccine Sales by Type (2017-2028)
7.2 North America Pet Vaccine Sales by Application (2017-2028)
7.3 North America Pet Vaccine Market Size by Country
7.3.1 North America Pet Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Pet Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Pet Vaccine Sales by Type (2017-2028)
8.2 Europe Pet Vaccine Sales by Application (2017-2028)
8.3 Europe Pet Vaccine Market Size by Country
8.3.1 Europe Pet Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Pet Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pet Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Pet Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Pet Vaccine Market Size by Region
9.3.1 Asia-Pacific Pet Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pet Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Pet Vaccine Sales by Type (2017-2028)
10.2 South America Pet Vaccine Sales by Application (2017-2028)
10.3 South America Pet Vaccine Market Size by Country
10.3.1 South America Pet Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Pet Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pet Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Pet Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Pet Vaccine Market Size by Country
11.3.1 Middle East & Africa Pet Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pet Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Pet Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pet Vaccine
12.3 Pet Vaccine Production Process
12.4 Pet Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pet Vaccine Typical Distributors
13.3 Pet Vaccine Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Pet Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pet Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Healthcare Major Business
Table 5. Bayer Healthcare Pet Vaccine Product and Services
Table 6. Bayer Healthcare Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Vetoquinol S.A Basic Information, Manufacturing Base and Competitors
Table 8. Vetoquinol S.A Major Business
Table 9. Vetoquinol S.A Pet Vaccine Product and Services
Table 10. Vetoquinol S.A Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Pet Vaccine Product and Services
Table 14. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ceva Basic Information, Manufacturing Base and Competitors
Table 16. Ceva Major Business
Table 17. Ceva Pet Vaccine Product and Services
Table 18. Ceva Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Pet Vaccine Product and Services
Table 22. Eli Lilly Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Heska Co. Basic Information, Manufacturing Base and Competitors
Table 24. Heska Co. Major Business
Table 25. Heska Co. Pet Vaccine Product and Services
Table 26. Heska Co. Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 28. Merck Animal Health Major Business
Table 29. Merck Animal Health Pet Vaccine Product and Services
Table 30. Merck Animal Health Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merial (Sanofi) Basic Information, Manufacturing Base and Competitors
Table 32. Merial (Sanofi) Major Business
Table 33. Merial (Sanofi) Pet Vaccine Product and Services
Table 34. Merial (Sanofi) Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Virbac Basic Information, Manufacturing Base and Competitors
Table 36. Virbac Major Business
Table 37. Virbac Pet Vaccine Product and Services
Table 38. Virbac Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Zoetis (Pfizer) Basic Information, Manufacturing Base and Competitors
Table 40. Zoetis (Pfizer) Major Business
Table 41. Zoetis (Pfizer) Pet Vaccine Product and Services
Table 42. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Pet Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 44. Global Pet Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Pet Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Pet Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 47. Head Office and Pet Vaccine Production Site of Key Manufacturer
Table 48. Pet Vaccine New Entrant and Capacity Expansion Plans
Table 49. Pet Vaccine Mergers & Acquisitions in the Past Five Years
Table 50. Global Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 51. Global Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 52. Global Pet Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Pet Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 55. Global Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 56. Global Pet Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Pet Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Pet Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 59. Global Pet Vaccine Price by Type (2023-2028) & (USD/Dose)
Table 60. Global Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 61. Global Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 62. Global Pet Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Pet Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Pet Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 65. Global Pet Vaccine Price by Application (2023-2028) & (USD/Dose)
Table 66. North America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 67. North America Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 68. North America Pet Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Pet Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 71. North America Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 72. North America Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 73. North America Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 74. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 75. Europe Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 76. Europe Pet Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Pet Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 79. Europe Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 80. Europe Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 81. Europe Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 82. Asia-Pacific Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 83. Asia-Pacific Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 84. Asia-Pacific Pet Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Pet Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 87. Asia-Pacific Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 88. Asia-Pacific Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 89. Asia-Pacific Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 90. South America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 91. South America Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 92. South America Pet Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Pet Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 95. South America Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 96. South America Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 97. South America Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 98. Middle East & Africa Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 99. Middle East & Africa Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 100. Middle East & Africa Pet Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Pet Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 103. Middle East & Africa Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 104. Middle East & Africa Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 105. Middle East & Africa Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 106. Pet Vaccine Raw Material
Table 107. Key Manufacturers of Pet Vaccine Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Pet Vaccine Typical Distributors
Table 111. Pet Vaccine Typical Customers
List of Figures
Figure 1. Pet Vaccine Picture
Figure 2. Global Pet Vaccine Revenue Market Share by Type in 2021
Figure 3. Attenuated Live Vaccines
Figure 4. Conjugate Vaccines
Figure 5. Inactivated Vaccines
Figure 6. Subunit Vaccines
Figure 7. Toxoid Vaccines
Figure 8. DNA Vaccines
Figure 9. Recombinant Vaccines
Figure 10. Global Pet Vaccine Revenue Market Share by Application in 2021
Figure 11. Canine
Figure 12. Avian
Figure 13. Feline
Figure 14. Global Pet Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 15. Global Pet Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Pet Vaccine Sales (2017-2028) & (K Doses)
Figure 17. Global Pet Vaccine Price (2017-2028) & (USD/Dose)
Figure 18. Global Pet Vaccine Production Capacity (2017-2028) & (K Doses)
Figure 19. Global Pet Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Pet Vaccine Market Drivers
Figure 21. Pet Vaccine Market Restraints
Figure 22. Pet Vaccine Market Trends
Figure 23. Global Pet Vaccine Sales Market Share by Manufacturer in 2021
Figure 24. Global Pet Vaccine Revenue Market Share by Manufacturer in 2021
Figure 25. Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Pet Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Pet Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Pet Vaccine Sales Market Share by Region (2017-2028)
Figure 29. Global Pet Vaccine Revenue Market Share by Region (2017-2028)
Figure 30. North America Pet Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Europe Pet Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Pet Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. South America Pet Vaccine Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Pet Vaccine Revenue (2017-2028) & (USD Million)
Figure 35. Global Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 36. Global Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 37. Global Pet Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 38. Global Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 39. Global Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 40. Global Pet Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 41. North America Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 42. North America Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 43. North America Pet Vaccine Sales Market Share by Country (2017-2028)
Figure 44. North America Pet Vaccine Revenue Market Share by Country (2017-2028)
Figure 45. United States Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 49. Europe Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 50. Europe Pet Vaccine Sales Market Share by Country (2017-2028)
Figure 51. Europe Pet Vaccine Revenue Market Share by Country (2017-2028)
Figure 52. Germany Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Pet Vaccine Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Pet Vaccine Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Pet Vaccine Revenue Market Share by Region (2017-2028)
Figure 61. China Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 68. South America Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 69. South America Pet Vaccine Sales Market Share by Country (2017-2028)
Figure 70. South America Pet Vaccine Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Pet Vaccine Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Pet Vaccine Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Pet Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Pet Vaccine in 2021
Figure 82. Manufacturing Process Analysis of Pet Vaccine
Figure 83. Pet Vaccine Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
